{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T13:13:59Z","timestamp":1774358039931,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urolithiasis"],"DOI":"10.1007\/s00240-026-01948-9","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:36:04Z","timestamp":1774355764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hydrogen sulfide ameliorates oxalate crystal-related renal injury via inhibiting the activation of NOD-like receptor thermal protein domain associated protein 3 inflammasome in mice"],"prefix":"10.1007","volume":"54","author":[{"given":"Yan","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lumiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiali","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiran","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qifei","family":"Cong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"issue":"1","key":"1948_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/bju.13828","volume":"120","author":"G Zeng","year":"2017","unstructured":"Zeng G et al (2017) Prevalence of kidney stones in china: an ultrasonography based cross-sectional study. BJU Int 120(1):109\u2013116","journal-title":"BJU Int"},{"key":"1948_CR2","doi-asserted-by":"publisher","first-page":"16008","DOI":"10.1038\/nrdp.2016.8","volume":"2","author":"SR Khan","year":"2016","unstructured":"Khan SR et al (2016) Kidney stones. Nat Rev Dis Prim 2:16008","journal-title":"Nat Rev Dis Prim"},{"issue":"5","key":"1948_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1053\/j.ajkd.2023.03.017","volume":"82","author":"S Shastri","year":"2023","unstructured":"Shastri S, Patel J, Sambandam KK, Lederer ED (2023) Kidney stone Pathophysiology, evaluation and management: core curriculum 2023. Am J Kidney Diseases: Official J Natl Kidney Foundation 82(5):617\u2013634","journal-title":"Am J Kidney Diseases: Official J Natl Kidney Foundation"},{"issue":"4","key":"1948_CR4","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1001\/jamainternmed.2018.7980","volume":"179","author":"SS Waikar","year":"2019","unstructured":"Waikar SS et al (2019) Association of urinary oxalate excretion with the risk of chronic kidney disease progression. JAMA Intern Med 179(4):542\u2013551","journal-title":"JAMA Intern Med"},{"issue":"5","key":"1948_CR5","first-page":"788","volume":"39","author":"M Puurunen","year":"2024","unstructured":"Puurunen M, Kurtz C, Wheeler A, Mulder K, Wood K, Swenson A, Curhan G (2024) Twenty-four-hour urine oxalate and risk of chronic kidney disease. Nephrology, dialysis, transplantation: official publication of the European Dialysis and transplant association -. Eur Ren Association 39(5):788\u2013794","journal-title":"Eur Ren Association"},{"issue":"12","key":"1948_CR6","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1089\/end.2020.0403","volume":"34","author":"W Sui","year":"2020","unstructured":"Sui W, Calvert JK, Kavoussi NL, Gould ER, Miller NL, Bejan CA, Hsi RS (2020) Association of chronic kidney disease stage with 24-Hour urine values among patients with nephrolithiasis. J Endourol 34(12):1263\u20131271","journal-title":"J Endourol"},{"key":"1948_CR7","doi-asserted-by":"publisher","first-page":"10274","DOI":"10.1038\/ncomms10274","volume":"7","author":"SR Mulay","year":"2016","unstructured":"Mulay SR et al (2016) Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis. Nat Commun 7:10274","journal-title":"Nat Commun"},{"issue":"6","key":"1948_CR8","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/ndt\/gfy239","volume":"34","author":"C Marti","year":"2019","unstructured":"Marti C, Ludwigl I et al (2019) Targeting kidney inflammation as a new therapy for primary hyperoxaluria? Nephrol Dial Transpl 34(6):908\u2013914","journal-title":"Nephrol Dial Transpl"},{"issue":"12","key":"1948_CR9","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","volume":"41","author":"Y He","year":"2016","unstructured":"He Y, Hara H, N\u00fa\u00f1ez G (2016) Mechanism and regulation of NLRP3 inflammasome activation [J]. Trends Biochem Sci 41(12):1012\u20131021","journal-title":"Trends Biochem Sci"},{"issue":"4","key":"1948_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.tibs.2022.10.002","volume":"48","author":"J Xu","year":"2023","unstructured":"Xu J, N\u00fa\u00f1ez G (2023) The NLRP3 inflammasome: activation and regulation. Trends Biochem Sci 48(4):331\u2013344","journal-title":"Trends Biochem Sci"},{"key":"1948_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fphys.2018.00114","volume":"9","author":"A Sharma","year":"2018","unstructured":"Sharma A, Tate M, Mathew G et al (2018) Oxidative stress and NLRP3-Inflammasome activity as significant drivers of diabetic cardiovascular complications:therapeutic implications [J]. Front Physiol 9:114","journal-title":"Front Physiol"},{"issue":"23","key":"1948_CR12","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.3390\/cells12232684","volume":"12","author":"CMC Andr\u00e9s","year":"2023","unstructured":"Andr\u00e9s CMC, de la P\u00e9rez JM, Andr\u00e9s Juan C, Plou FJ, P\u00e9rez-Lebe\u00f1a E (2023) Chemistry of hydrogen Sulfide-Pathological and physiological functions in mammalian cells. Cells 12(23):2684","journal-title":"Cells"},{"issue":"1","key":"1948_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1152\/physrev.00028.2021","volume":"103","author":"G Cirino","year":"2023","unstructured":"Cirino G, Szabo C, Papapetropoulos A (2023) Physiological roles of hydrogen sulfide in mammalian cells, tissues, and organs. Physiol Rev 103(1):31\u2013276","journal-title":"Physiol Rev"},{"issue":"2","key":"1948_CR14","doi-asserted-by":"publisher","first-page":"E269","DOI":"10.1152\/ajpendo.00251.2018","volume":"317","author":"AS Papu John","year":"2019","unstructured":"Papu John AS et al (2019) Hydrogen sulfide inhibits Ca(2+)-induced mitochondrial permeability transition pore opening in type-1 diabetes. Am J Physiol Endocrinol Metab 317(2):E269\u2013E283","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1948_CR15","doi-asserted-by":"publisher","first-page":"119466","DOI":"10.1016\/j.lfs.2021.119466","volume":"284","author":"J Ni","year":"2021","unstructured":"Ni J (2021) etal.,Hydrogensulfide reduces pyroptosis and alleviates ischemia-reperfusion-induced acute kidney injury by inhibiting NLRP3 inflammasome. Life Sci 284:119466","journal-title":"Life Sci"},{"issue":"6","key":"1948_CR16","doi-asserted-by":"publisher","first-page":"771","DOI":"10.33549\/physiolres.934905","volume":"71","author":"F Ma","year":"2022","unstructured":"Ma F, Zhu Y, Chang L et al (2022) Hydrogen sulfide protects against ischemic heart failure by inhibiting RIP1\/RIP3\/MLKL-mediated necroptosis. Physiol Res 71(6):771\u2013781","journal-title":"Physiol Res"},{"key":"1948_CR17","doi-asserted-by":"publisher","first-page":"713536","DOI":"10.3389\/fmed.2021.713536","volume":"8","author":"Y Si","year":"2021","unstructured":"Si Y et al (2021) Oral Hydrogen-Rich water alleviates Oxalate-Induced kidney injury by suppressing oxidative Stress, Inflammation, and fibrosis. Front Med (Lausanne) 8:713536","journal-title":"Front Med (Lausanne)"},{"key":"1948_CR18","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/s12276-024-01261-8","volume":"56","author":"R Ramachandran","year":"2024","unstructured":"Ramachandran R, Manan A, Kim J et al (2024) NLRP3 inflammasome: a key player in the pathogenesis of life-style disorders. Exp Mol Med 56:1488\u20131500","journal-title":"Exp Mol Med"},{"key":"1948_CR19","doi-asserted-by":"crossref","unstructured":"Liu L, Wang Y, Yan R, Liang L, Zhou X, Liu H, Zhang X, Mao Y, Peng W, Xiao Y, Zhang F, Liu L, Shi M, Guo B (2019) BMP-7 inhibits renal fibrosis Indiabetic nephropathy via miR-21 downregulation. Life Sci 238(1):116957","DOI":"10.1016\/j.lfs.2019.116957"},{"issue":"6","key":"1948_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41581-020-00392-1","volume":"17","author":"SR han Canales","year":"2021","unstructured":"han Canales SR, Dominguez-Gutierrez BK (2021) Ran- dall\u2019s plaque and calcium oxalate stone formation: role for immunity and inflammation[J]. Nat Rev Nephrol 17(6):417\u2013433","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"1948_CR21","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41419-023-05830-z","volume":"14","author":"Z Chen","year":"2023","unstructured":"Chen Z, Li Y, Yuan Y, Lai K, Ye K, Lin Y, Lan R, Chen H, Xu Y (2023) Single-cell sequencing reveals homogeneity and heterogeneity of the cytopathological mechanisms in different etiology-induced AKI. Cell Death Dis 14(5):318","journal-title":"Cell Death Dis"},{"issue":"12","key":"1948_CR22","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41581-020-0320-7","volume":"16","author":"C Thongprayoon","year":"2020","unstructured":"Thongprayoon C, Krambeck AE, Rule AD (2020) Determining the true burden of kidney stone disease. Nat Rev Nephrol 16(12):736\u2013746","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"1948_CR23","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.3390\/nu15112607","volume":"15","author":"I Coello","year":"2023","unstructured":"Coello I, Sanchis P, Pieras EC, Grases F (2023) Diet in different calcium oxalate kidney stones. Nutrients 15(11):2607","journal-title":"Nutrients"},{"issue":"4","key":"1948_CR24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4103\/0971-4065.114481","volume":"23","author":"G Bakul","year":"2013","unstructured":"Bakul G et al (2013) Acute oxalate nephropathy due to \u2018Averrhoa bilimbi\u2019 fruit juice ingestion. Indian J Nephrol 23(4):297\u2013300","journal-title":"Indian J Nephrol"},{"issue":"16","key":"1948_CR25","doi-asserted-by":"publisher","first-page":"7319","DOI":"10.7150\/thno.44054","volume":"10","author":"H Liu","year":"2020","unstructured":"Liu H et al (2020) Sulforaphane elicts dual therapeutic effects on renal inflammatory injury and crystal deposition in calcium oxalate nephrocalcinosis. Theranostics 10(16):7319\u20137334","journal-title":"Theranostics"},{"key":"1948_CR26","doi-asserted-by":"publisher","first-page":"111779","DOI":"10.1016\/j.yexcr.2019.111779","volume":"387","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Zhu X, Wang X, Peng Y, Du J, Yin H et al (2020) H2S alleviates renal injury and fibrosis in response to unilateral ureteral obstruction by regulating macrophage infiltration via Inhibition of NLRP3 signaling. Exp Cell Res 387:111779","journal-title":"Exp Cell Res"},{"key":"1948_CR27","first-page":"1","volume":"2018","author":"Y Chen","year":"2018","unstructured":"Chen Y, Jin S, Teng X, Hu Z, Zhang Z, Qiu X et al (2018) Hydrogen sulfide attenuates LPS-induced acute kidney injury by inhibiting inflammation and oxidative stress. Oxid Med Cell Longev 2018:1\u201310","journal-title":"Oxid Med Cell Longev"},{"key":"1948_CR28","doi-asserted-by":"crossref","unstructured":"Akbari M, Sogutdelen E, Juriasingani S, Sener A (2019) Hydrogen sulfide:emerging role in bladder, kidney, and prostate malignancies. Oxid. Med. Cell.Longev. 2019, 2360945","DOI":"10.1155\/2019\/2360945"},{"key":"1948_CR29","first-page":"474","volume":"71","author":"OS Khukhlina","year":"2018","unstructured":"Khukhlina OS (2018) The role of hydrogen sulfide in the progressionmechanisms ofnon-alcoholic steatohepatitis and chronic kidney disease. Wiad Lek 71:474\u2013478","journal-title":"Wiad Lek"},{"issue":"1","key":"1948_CR30","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3892\/mmr.2021.12157","volume":"24","author":"Y Su","year":"2021","unstructured":"Su Y, Wang Y, Liu M, Chen H (2021) Hydrogen sulfide attenuates renal I\/R\u2013induced activation of the inflammatory response and apoptosis via regulating Nrf2\u2013mediated NLRP3 signaling pathway Inhibition. Mol Med Rep 24(1):518","journal-title":"Mol Med Rep"},{"issue":"2","key":"1948_CR31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12192-019-01055-2","volume":"25","author":"NM Aziz","year":"2020","unstructured":"Aziz NM, Elbassuoni EA, Kamel MY, Ahmed SM (2020) Hydrogen sulfide renal protective effects: possible link between hydrogen sulfide and endogenous carbon monoxide in a rat model of renal injury. Cell Stress Chaperones 25(2):211\u2013221","journal-title":"Cell Stress Chaperones"},{"issue":"5","key":"1948_CR32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00240-020-01202-w","volume":"48","author":"R Geraghty","year":"2020","unstructured":"Geraghty R, Wood K, Sayer JA (2020) Calcium oxalate crystal deposition in the kidney: identification, causes and consequences. Urolithiasis 48(5):377\u2013384","journal-title":"Urolithiasis"},{"key":"1948_CR33","doi-asserted-by":"publisher","first-page":"818625","DOI":"10.3389\/fimmu.2022.818625","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Sun Y, Kang J, He Z, Liu Q, Wu J et al (2022) Role of ROS-induced NLRP3 inflammasome activation in the formation of calcium oxalate nephrolithiasis. Front Immunol 13:818625","journal-title":"Front Immunol"},{"key":"1948_CR34","doi-asserted-by":"publisher","first-page":"1614438","DOI":"10.3389\/fphys.2025.1614438","volume":"16","author":"AM Boldt","year":"2025","unstructured":"Boldt AM, Di Sole F (2025) Targeting the NLRP3 inflammasome for calcium oxalate stones: pathophysiology and emerging Pharmacological interventions. Front Physiol 16:1614438","journal-title":"Front Physiol"},{"issue":"1","key":"1948_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s00240-025-01716-1","volume":"53","author":"Y Xu","year":"2025","unstructured":"Xu Y, Li G, Liu W, Ge D, Hao Z, Wang W (2025) Inhibition of NLRP3 alleviates calcium oxalate crystal-induced renal fibrosis and crystal adhesion. Urolithiasis 53(1):44","journal-title":"Urolithiasis"},{"key":"1948_CR36","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1002\/jcp.27102","volume":"234","author":"LSLY W.W","year":"2019","unstructured":"W.W LSLY, K.Z DX, W W (2019) Peroxisome proliferator-activated receptor \u03b3 modulates renal crystal retention associated with high oxalate concentration by regulating tubular epithelial cellular transdifferentiation. J Cell Physiol 234:2837\u20132850","journal-title":"J Cell Physiol"},{"key":"1948_CR37","doi-asserted-by":"publisher","first-page":"45740","DOI":"10.1038\/srep45740","volume":"7","author":"C MB","year":"2017","unstructured":"MB C, EA P, E C, MA dG, N S, FT B (2017) Calcium oxalate crystals and oxalate induce an epithelial-to-mesenchymal transition in the proximal tubular epithelial cells:contribution to oxalate kidney injury. Sci Rep 7:45740","journal-title":"Sci Rep"},{"key":"1948_CR38","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1159\/000495827","volume":"51","author":"T H","year":"2018","unstructured":"H T, J Y, Z X, J L (2018) Gliquidone alleviates diabetic nephropathy by inhibiting notch\/snail signaling pathway. Cell Physiol Biochemistry: Int J Experimental Cell Physiol Biochem Pharmacol 51:2085\u20132097","journal-title":"Cell Physiol Biochemistry: Int J Experimental Cell Physiol Biochem Pharmacol"},{"key":"1948_CR39","doi-asserted-by":"publisher","first-page":"117336","DOI":"10.1016\/j.biopha.2024.117336","volume":"179","author":"W Zhu","year":"2024","unstructured":"Zhu W, Qiong D, Changzhi X, Meiyu J, Hui L (2024) Macrophage polarization regulation shed lights on immunotherapy for CaOx kidney stone disease. Biomed Pharmacother 179:117336","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1948_CR40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00240-025-01732-1","volume":"53","author":"T Hattori","year":"2025","unstructured":"Hattori T, Taguchi K, Chaya R, Hamamoto S, Okada A, Yasui T (2025) The role of osteopontin in modulating macrophage phagocytosis of calcium oxalate crystals. Urolithiasis 53(1):58","journal-title":"Urolithiasis"},{"issue":"7","key":"1948_CR41","doi-asserted-by":"publisher","first-page":"11463","DOI":"10.1002\/jcp.27803","volume":"234","author":"J Xi","year":"2019","unstructured":"Xi J, Chen Y, Jing J et al (2019) Sirtuin 3 suppresses the for- mation of renal calcium oxalate crystals through promoting M2 polarization of macrophages. J Cell Physiol 234(7):11463\u201311473","journal-title":"J Cell Physiol"},{"issue":"2","key":"1948_CR42","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.apsb.2021.08.001","volume":"12","author":"H Chen","year":"2022","unstructured":"Chen H, Hu K, Liang Y et al (2022) Ample dietary fat re- duced the risk of primary vesical calculi by inducing mac\u2010 rophages to engulf budding crystals in mice. Acta Pharm Sin B 12(2):747\u2013758","journal-title":"Acta Pharm Sin B"}],"container-title":["Urolithiasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-026-01948-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00240-026-01948-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-026-01948-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:36:08Z","timestamp":1774355768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00240-026-01948-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1948"],"URL":"https:\/\/doi.org\/10.1007\/s00240-026-01948-9","relation":{},"ISSN":["2194-7236"],"issn-type":[{"value":"2194-7236","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This work is supported by grants from the National Natural Science Foundation of China (NO. 32200778), Natural Science Foundation of Jiangsu Province (NO. BK20220494), Suzhou Medical and Health Technology Innovation Project (NO. SKY2022107), the Clinical Research Center of Neurological Disease in The Second Affiliated Hospital of Soochow University (NO. ND2022A04), State Key Laboratory of Drug Research (NO. SKLDR-2023-KF-05), Jiangsu Shuangchuang Program for Doctor, Young Science Talents Promotion Project of Jiangsu Science and Technology Association (TJ-2023-019).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Acknowledgments"}}],"article-number":"71"}}